Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Traditional Chinese Medicine Holdings Co (STU:WSG) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
China Traditional Chinese Medicine Holdings Co Equity-to-Asset Related Terms
China Traditional Chinese Medicine Holdings Co Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Traditional Chinese Medicine Holdings Co Equity-to-Asset Chart
China Traditional Chinese Medicine Holdings Co Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, China Traditional Chinese Medicine Holdings Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Traditional Chinese Medicine Holdings Co Equity-to-Asset vs Drug Manufacturers Industry
China Traditional Chinese Medicine Holdings Co Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Traditional Chinese Medicine Holdings Co (STU:WSG) has a Equity-to-Asset of 0.63 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on China Traditional Chinese Medicine Holdings Co and its competitors. This is 15% above median its historical median of 0.55. Over the past decade, China Traditional Chinese Medicine Holdings Co's Equity-to-Asset has ranged from 0.50 to 0.63. According to the industry distribution chart, China Traditional Chinese Medicine Holdings Co ranks #454 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 45.2%.
Is China Traditional Chinese Medicine Holdings Co's Equity-to-Asset too high?
China Traditional Chinese Medicine Holdings Co's current Equity-to-Asset of 0.63 is 15% above median its 10-year median of 0.55. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 0.63. The Drug Manufacturers industry median Equity-to-Asset is 0.60. China Traditional Chinese Medicine Holdings Co's value of 0.63 is 5% above this industry median. Based on the distribution chart, China Traditional Chinese Medicine Holdings Co ranks #454 out of 1005 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, China Traditional Chinese Medicine Holdings Co has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does China Traditional Chinese Medicine Holdings Co's Equity-to-Asset compare to ZTS?
According to the Drug Manufacturers industry distribution chart, China Traditional Chinese Medicine Holdings Co ranks #454 out of 1005 companies for Equity-to-Asset. This puts China Traditional Chinese Medicine Holdings Co in the upper half of its industry. The industry median Equity-to-Asset is 0.60. China Traditional Chinese Medicine Holdings Co's value of 0.63 is 5% above this benchmark. Historically, China Traditional Chinese Medicine Holdings Co's own Equity-to-Asset has ranged from 0.50 to 0.63 over the past decade. While the company's 10-year median is 0.55 vs. the industry median of 0.60, China Traditional Chinese Medicine Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.60, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Traditional Chinese Medicine Holdings Co's current Equity-to-Asset of 0.63 is 5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on China Traditional Chinese Medicine Holdings Co and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Traditional Chinese Medicine Holdings Co's current Equity-to-Asset is 0.63, which is 15% above median its own 10-year median of 0.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Traditional Chinese Medicine Holdings Co stock overvalued right now?
China Traditional Chinese Medicine Holdings Co (STU:WSG) has a current Equity-to-Asset of 0.63. The stock's GF Value™ is €0.42, compared to a current price of €0.22 — trading 47.6% below its estimated fair value. The current Equity-to-Asset is 0.63, which is 15% above median its 10-year median of 0.55 and 5% above the Drug Manufacturers industry median of 0.60. China Traditional Chinese Medicine Holdings Co's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For China Traditional Chinese Medicine Holdings Co (STU:WSG), the current Equity-to-Asset is 0.63 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Traditional Chinese Medicine Holdings Co (STU:WSG) Overvalued in 2026?
Based on GuruFocus' analysis, China Traditional Chinese Medicine Holdings Co stock appears to be undervalued.
The current stock price of €0.22 is trading 47.6% below its estimated GF Value™ of €0.42.
Key valuation signals for STU:WSG:
Equity-to-Asset: 0.63 (15% above median its 10-year median of 0.55)
GF Value™: €0.42 vs. price of €0.22 (47.6% below fair value)
Industry Position: 5% above the Drug Manufacturers median (#454 of 1005)
No single metric tells the full story. See the STU:WSG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Traditional Chinese Medicine Holdings Co Ltd is engaged in the Chinese healthcare sector. The company functions through four segments: Yi Fang, Tian Jiang, Tong Ji Tang, and Medi-World. It generates maximum revenue from the Yifang segment which mainly engages in the manufacture and sales of concentrated TCM granules (CTCMG), TCM healthcare products, and TCM decoction pieces under the Yi Fang brand. The majority of the revenue of the Yi Fang segment is derived from the sales of CTCMG. Geographically, it derives a majority of its revenue from Mainland China, and also has its presence in Hong Kong and Other countries.
71GF Score
Get the complete analysis for STU:WSG
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:WSG has been successfully added to your 
